[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-363368-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-363368-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-integrated-stress-response-promotes-immune-evasion-through-lipocalin-2","The integrated stress response promotes immune evasion through lipocalin 2","","Cancer cells activate the integrated stress response (ISR) to adapt to stress and resist therapy, with ISR signals converging on ATF4, a key regulator of metabolic adaptation, survival, and growth. Yet how the ISR–ATF4 axis shapes anti-tumour immunity was unclear. Here, ATF4 loss reduces tumour progression in immunocompetent mice by enhancing T cell-dependent anti-cancer responses, identifying lipocalin 2 (LCN2) as an ATF4 effector that supports immunosuppressive macrophage infiltration, T cell exclusion, and immune evasion. LCN2 aligns with reduced T cell infiltration in patient lung and pancreatic adenocarcinomas.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-integrated-stress-response-promotes-immune-evasion-through-lipocalin-2/363368/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-integrated-stress-response-promotes-immune-evasion-through-lipocalin-2/363368.png","ImageObject",300,407,{"name":42,"@type":43},"Pentious","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-02","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role does the integrated stress response (ISR) play in cancer?","Question",{"text":63,"@type":64},"Cancer cells activate the ISR to adapt to stress and resist therapy. ISR signaling activates ATF4, which regulates transcriptional programs supporting survival and growth.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does ATF4 loss affect tumours in different mouse immune contexts?",{"text":68,"@type":64},"Loss of ATF4 decreases tumour progression in immunocompetent mice, enhancing T cell-dependent anti-cancer immune responses, but it does not show the same effect in immunocompromised ones.",{"name":70,"@type":61,"acceptedAnswer":71},"Why is lipocalin 2 (LCN2) important for immune evasion?",{"text":72,"@type":64},"An unbiased genetic screen identifies LCN2 as a principal ATF4-dependent effector that impairs anti-tumour immunity by favoring immunosuppressive macrophage infiltration, promoting T cell exclusion, and enabling immune evasion in preclinical models.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},363368,1790996275,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":113,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1374404730887,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Article  \n\n| The integrated stress response promotes immune evasion through lipocalin 2 |  |  |\n| --- | --- | --- |\n| [https://doi.org/10.1038/s41586-026-10143-0](https://doi.org/10.1038/s41586-026-10143-0) | Jozef P. Bossowski1,23, Ray Pillai1,2,3,23, John Kilian4,5, Angela Wong Lau6,7, Mari Nakamura1,5, Ali Rashidfarrokhi1,4, Yuan Hao1,8, Ruxuan Li6,7, Katherine Wu1,5, Takamitsu Hattori4,9, Eliezra Glasser4, Akiko Koide4,10, Lidong Wang9,11, Andre L. Moreira1,12, Cristina Hajdu1, Sahith Rajalingam1, Sarah E. LeBoeuf1, Hortense Le1,13, Seungeun Lee14, Jin Woo Oh14, Cheolyong Joe15,16, Hyemin Kim15, Chan-Young Ock14, Se-Hoon Lee15,16, Hao Wang1, Angana A. H. Patel17,18, Volkan I. Sayin17,18, Aristotelis Tsirigos1,8, Kwok-Kin Wong1,19, Sergei B. Koralov1,4, Mario Pende20, Francisco J. Sánchez-Rivera21,22, Diane M. Simeone11, Ioannis K. Zervantonakis6,7, Shohei Koide4,9 ✉ & Thales Papagiannakopoulos1,4 ✉\u003Cbr>Cancer cells activate the integrated stress response (ISR) to adapt to stress and resist therapy1. ISR signals converge on activating transcription factor 4 (ATF4), which controls cell-intrinsic transcriptional programs that are involved in metabolic adaptation, survival and growth2,3. However, whether the ISR–ATF4 axis influences anti-tumour immune responses remains mostly unknown. Here we show that loss of ATF4 decreases tumour progression considerably in immunocompetent mice, but not in immunocompromised ones, by enhancing T cell-dependent anti-cancer immune responses. An unbiased genetic screen of ATF4-regulated genes identifies lipocalin 2 (LCN2) asthe principal ATF4-dependent effector that impairsanti-tumour immunity by favouring infiltration with immunosuppressive interstitial macrophages. Furthermore, we find that LCN2 promotesT cell exclusion and immune evasion in preclinical mouse models, and correlates with decreased T cell infiltration inpatients with lung and pancreatic adenocarcinomas. Anti-LCN2 antibodies promote robust anti-tumour T cell responsesin mouse models of aggressive solid tumours. Our study shows that the ATF4–LCN2 axis has a cell-extrinsic role in suppressing anti-cancer immunity, and could pave the way for an immunotherapy approach that targets LCN2. |  |\n| Received: 13 June 2024 |  |  |\n| Accepted: 15 January 2026 |  |  |\n| Published online: 18 February 2026 |  |  |\n| Open access |  |  |\n|  Check for updates |  |  |\n| Immune checkpoint inhibitors (ICIs) have transformed anti-cancer |  | conserved cellular defence system that is triggered by diverse |\n| therapy and become a first-line treatment for several cancers4,5. How- |  | stressors, including misfolded proteins, amino acid starvation and |\n| ever, many solid tumours do not respond to standard-of-care ICIs6–8. |  | mitochondrial dysfunction1,3,11,14–19. The central driver of ISR acti- |\n| Gaining a better understanding of the mechanisms that underlie |  | vation is the phosphorylation of eukaryotic translation initiation |\n| immune evasion of ICI-refractory cancers is therefore essential to |  | factor 2α (eIF2α), which reduces global translation while selec- |\n| improve anti-cancer treatments8,9. |  | tively promoting the translation of activating transcription factor |\n| Solid tumours progressively reshape their immediate tumour |  | 4 (ATF4), a central regulator of transcriptional programs that sup- |\n| microenvironment (TME), producing features that affect the fit- |  | port adaptation and survival1. The ISRand its master transcriptional |\n| ness and characteristics of cells within the TME, such as hypoxia, |  | effector, ATF4, are emerging as key players that respond to several |\n| nutrient scarcity and waste accumulation1,10–13. In response, cancer |  | intrinsic stressors during tumorigenesis and contribute to therapy |\n| cells activate the integrated stress response (ISR), an evolutionarily |  | resistance1–3,15,17,18,20. |\n\n1Department of Pathology, New York University Grossman School of Medicine, New York, NY, USA. 2Division of Pulmo","cbCaisRo4iv20Rn2","https://ap.wps.com/l/cbCaisRo4iv20Rn2","pdf",50978704,"English","# Background\n## ISR, ATF4, and immune evasion\n# Key Findings\n## ATF4 loss and T cell-dependent anti-cancer immunity\n## LCN2 as the ATF4-dependent effector\n## LCN2-mediated T cell exclusion and clinical correlations\n## Therapeutic potential of anti-LCN2 antibodies","[{\"question\":\"What role does the integrated stress response (ISR) play in cancer?\",\"answer\":\"Cancer cells activate the ISR to adapt to stress and resist therapy. ISR signaling activates ATF4, which regulates transcriptional programs supporting survival and growth.\"},{\"question\":\"How does ATF4 loss affect tumours in different mouse immune contexts?\",\"answer\":\"Loss of ATF4 decreases tumour progression in immunocompetent mice, enhancing T cell-dependent anti-cancer immune responses, but it does not show the same effect in immunocompromised ones.\"},{\"question\":\"Why is lipocalin 2 (LCN2) important for immune evasion?\",\"answer\":\"An unbiased genetic screen identifies LCN2 as a principal ATF4-dependent effector that impairs anti-tumour immunity by favoring immunosuppressive macrophage infiltration, promoting T cell exclusion, and enabling immune evasion in preclinical models.\"}]","The integrated stress response promotes immune evasion through lipocalin 2 | PDF",1790150967,76,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bdd49a0bbc85865a0f341c6f81fee4fb.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e186eb7f511422e61445bb75a3e40974.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f69dc47685d97d03e233b6cafa68e711.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/240f55af65faab00761f2bc6433ef5aa.webp",980,1301]